190 related articles for article (PubMed ID: 37401254)
41. Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.
Frade MAC; Coltro PS; Filho FB; Horácio GS; Neto AA; da Silva VZ; Westin AT; Guimarães FR; Innocentini LMAR; Motta ACF; Farina JA
Indian J Dermatol Venereol Leprol; 2022; 88(4):464-477. PubMed ID: 34672479
[TBL] [Abstract][Full Text] [Related]
42. Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?
Sánchez-Martínez EM; Melgosa-Ramos FJ; Moneva-Léniz LM; Gegúndez-Hernández H; Prats-Máñez A; Mateu-Puchades A
Int J Dermatol; 2021 Feb; 60(2):e74-e76. PubMed ID: 32970828
[No Abstract] [Full Text] [Related]
43. Erythema nodosum leprosum (type 2 reaction) in a patient with neurofibromatosis type 1.
George R; D'Souza S; Masoodi I
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 34992063
[TBL] [Abstract][Full Text] [Related]
44. Reverse Koebner phenomenon in erythema nodosum leprosum.
Singh S; Narang T; Dogra S
Trans R Soc Trop Med Hyg; 2024 Jan; 118(1):77-79. PubMed ID: 37632458
[TBL] [Abstract][Full Text] [Related]
45. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
46. Target/therapies for chronic recurrent erythema nodosum leprosum.
Thangaraju P; Varthya SB; Venkatesan S
Indian J Pharmacol; 2020; 52(3):222-226. PubMed ID: 32874007
[TBL] [Abstract][Full Text] [Related]
47. Autochthonous leprosy in Europe: a case report and literature review.
Beauvillain Q; Lok C; Joachim C; Hamdad F; Lafabregue E; Attencourt C; Sevestre H; Chaby G
Int J Infect Dis; 2021 Sep; 110():111-113. PubMed ID: 34271204
[TBL] [Abstract][Full Text] [Related]
48. Histopathological study of ocular erythema nodosum leprosum and post-therapeutic scleral perforation: a case report.
Rathinam SR; Khazaei HM; Job CK
Indian J Ophthalmol; 2008; 56(5):417-9. PubMed ID: 18711273
[TBL] [Abstract][Full Text] [Related]
49. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
50. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
Pandhi D; Mehta S; Agrawal S; Singal A
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
[TBL] [Abstract][Full Text] [Related]
51. Erythema nodosum leprosum mimicking Sweet's syndrome: an uncommon presentation.
Mahajan VK; Abhinav C; Mehta KS; Chauhan PS
Lepr Rev; 2014 Dec; 85(4):322-7. PubMed ID: 25675656
[TBL] [Abstract][Full Text] [Related]
52. Necrotic erythema nodosum reaction associated with histological alterations of Lucio's phenomenon.
Góes LDM; Morais PM; Rebello PFB; Schettini APM
An Bras Dermatol; 2022; 97(2):231-235. PubMed ID: 34996656
[TBL] [Abstract][Full Text] [Related]
53. Type II reaction without erythema nodosum leprosum masquerading as lymphoma.
Mahajan R; Dogra S; Kaur I; Yadav S; Saikia UN; Budania A
Lepr Rev; 2012 Dec; 83(4):378-83. PubMed ID: 23614256
[TBL] [Abstract][Full Text] [Related]
54. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
55. Histoid leprosy: a retrospective study of 40 cases from India.
Kaur I; Dogra S; De D; Saikia UN
Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
[TBL] [Abstract][Full Text] [Related]
56. Lepromatous leprosy in erythema nodosum leprosum reaction mimicking Sweet's syndrome.
Heng YK; Chiam YT; Giam YC; Chong WS
Int J Dermatol; 2011 Sep; 50(9):1124-5. PubMed ID: 22126876
[No Abstract] [Full Text] [Related]
57. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
58. Erythema nodosum leprosum in histoid leprosy: a case report.
Kumar V; Mendiratta V; Sharma RC; Kakar N; Bajaj P
J Dermatol; 1997 Sep; 24(9):611-4. PubMed ID: 9350110
[TBL] [Abstract][Full Text] [Related]
59. Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum.
Nath I; Vemuri N; Reddi AL; Bharadwaj M; Brooks P; Colston MJ; Misra RS; Ramesh V
Lepr Rev; 2000 Dec; 71 Suppl():S130-7. PubMed ID: 11201870
[TBL] [Abstract][Full Text] [Related]
60. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
